Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 2016 Sep;186(9):2337–2352. doi: 10.1016/j.ajpath.2016.07.001

Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus

Jobert G Barin , Monica V Talor , Julie A Schaub , Nicola L Diny , Xuezhou Hou , Matthew Hoyer , Nathan K Archer , Elizabeth S Gebremariam , Meghan F Davis §, Lloyd S Miller , Noel R Rose ∗,, Daniela Čiháková ∗,†,
PMCID: PMC5012512  PMID: 27470712

Abstract

Infections with Staphylococcus aureus are a continuing and growing problem in community and hospital settings. Preclinical animal modeling of S. aureus relies on experimental infection, which carries some limitations. We describe here a novel, spontaneous model of oral staphylococcal infection in double knockout mice, deficient in the receptors for IL-17 (IL-17RA) and interferon (IFN)-γ (IFNγRI), beginning at 6 to 8 weeks of age. IFNγRI−/−IL17RA−/− (GRAKO) mice developed progressive oral abscesses. Cytometric methods revealed extensive neutrophilic infiltration of oral tissues in GRAKO mice; further investigation evidenced that IL-17 predominated neutrophil defects in these mice. To investigate the contribution of IFN-γ signaling to this native host defense to S. aureus, we observed perturbations of monocyte recruitment and macrophage differentiation in the oral tissues of GRAKO mice, and CXCL9/chemokine ligand receptor (CXCR)3-driven recruitment of T-cell oral tissues and draining lymph nodes. To address the former finding, we depleted macrophages and monocytes in vivo from IL17RA−/− mice using liposomes loaded with clodronate. This treatment elicited oral abscesses, recapitulating the phenotype of GRAKO mice. From these findings, we propose novel collaborative functions of IL-17 and IFN-γ, acting through neutrophils and macrophages, respectively, in native mucocutaneous host defenses to S. aureus.


The complex interplay between the effector program of Th1 cells, controlled by interferon (IFN)-γ signaling, and the Th17 program predominated by IL-17 signaling, remains an active area of investigation. To investigate the relation between IFN-γ and IL-17A in our mouse model of autoimmune heart disease, we generated double-knockout mutants lacking both IFN-γ and IL-17A and reported that these mice develop a particularly severe, fatal eosinophilic form of autoimmune heart disease bearing hallmarks of Th2 deviation.1 As part of these studies, we set out to concurrently delete the cognate receptors for these cytokines—IFNγRI and IL17RA, respectively. In the process of establishing IFNγRI−/−IL17RA−/− (GRAKO) double-knockout mice, we found that these mice began spontaneously developing oral abscesses which, on testing, were determined to be uncontrolled infections with Staphylococcus aureus.

S. aureus is a Gram-positive member of the Firmicutes phylum, commonly found at cutaneous and mucosal surfaces in healthy mammalian hosts as a commensal organism. However, acquisition of virulence factors or immune compromise of the host can lead to opportunistic invasion and infection.2 Patient infections with S. aureus in hospital and community settings are a growing problem, particularly given the ongoing emergence of antibiotic resistance.3

Clear roles for IL-17 signaling and associated pathways in staphylococcal infections have been well established in experimental infection models.4 In these studies, expression of IL-17 by cutaneous γδ cells was essential in supporting rapid local recruitment of neutrophils, which in turn supported Th17 differentiation through IL-1β, forming a positive feed-forward circuit at the site of infection.5, 6 However, unambiguous protective roles for IFN-γ from S. aureus have not been as clearly delineated, in part because many of these studies preceded the Th17 paradigm.7, 8, 9, 10

The spontaneous staphylococcal disease of our IFNγRI−/−IL17RA−/− model pointed us toward a novel role for IFN-γ in this host defense process with a requisite interaction with IL-17–dependent signaling. The purpose of this work was to first characterize the disease of IFNγRI−/−IL17RA−/− double-knockout mice and then to examine their immunologic phenotype and function to elucidate the mechanisms underlying the severe spontaneous oral infections of IFNγRI−/−IL17RA−/− mice. From these studies, we find evidence for novel collaborative interactions between neutrophils and macrophages, as effectors of immunity driven by IL-17 and IFN-γ signaling, respectively.

Materials and Methods

Mice

Wild-type BALB/cJ mice and founder IFNγRI−/− BALB/c mice were commercially sourced (The Jackson Laboratory, Bar Harbor, ME). IL17RA−/− BALB/c founder mice were the generous provision of Amgen (Thousand Oaks, CA), through Dr. Jay Kolls (University of Pittsburgh, Pittsburgh, PA). To establish the IFNγRI−/−IL17RA−/− double-knockout strain, IFNγRI−/− and IL17RA−/− mice were intercrossed for one generation. [F1] hybrid progeny were further backcrossed to the IFNγRI−/− background to fix the Ifngr1 locus at homozygosity of the knockout allele, then intercrossed to generate IFNγRI−/−IL17RA−/− double-knockouts. Following emergence of the disease phenotype, the colony was maintained at hemizygosity at the Il17ra locus to limit disease among breeders. For some experiments, Thy1.1+ BALB/c congenic mice were substituted for wild-type controls, and IL17RA−/−CD45.1+ mice for IL17RA−/− mice. All mice were maintained in the Johns Hopkins University School of Medicine specific pathogen–free vivarium. Experiments were conducted in compliance with the Animal Welfare Act and the principles set forth in the Guide for the Care and Use of Laboratory Animals.11 All methods and protocols were approved by the Animal Care and Use Committee of the Johns Hopkins University.

Macrophage and Neutrophil Depletions

For mononuclear phagocyte system (MPS) depletions, clodronate- and phosphate-buffered saline-loaded liposomes (ClondronateLiposomes.com, Amsterdam, the Netherlands) were administered intraperitoneally, 200 μL per mouse, twice per week, for up to 6 weeks. For neutrophil depletions, IFNγRI−/− mice were administered 500 μg of anti-Ly6G monoclonal antibody (mAb) 1A8 (or isotype control rat IgG2a mAb 2A3; Bio X-Cell, West Lebanon, NH) intraperitoneally on days 0 and 2, followed by 250 μg maintenance doses b.i.d. for 4 weeks. Pathology, cytometry, and microbiology were performed at termination of the experiment.

Histopathology

Tissues were fixed in SafeFix (Thermo Fisher Scientific, Waltham, MA) and embedded, and 5-μm step sections were cut and stained with hematoxylin and eosin (H&E), or Brown & Brenn (Histoserv, Germantown, MD). Scoring was based on a weighted composite score of six criteria, each graded on a 0 to 4 scale: presence of abscess, bacteria, infiltration with polymorphonuclear or mononuclear cells, and inflammatory involvement of epidermis or dermis—the first two weighted doubly, then added, resulting in a 1 to 32 scale.

Flow Cytometry

Oral tissues were digested in 10 mg Liberase TL (Roche, Basel, Switzerland), 100 mg Dispase (Roche), 100 mg collagenase II (Worthington Biochemical Corporation, Lakewood, NJ), and 0.1 mg/mL DNase I (Worthington Biochemical Corporation) for 90 minutes at 37°C, followed by suspension in gentle MACS C Tubes (Miltenyi Biotec, Gladbach, Germany). Lymph node (LN) cells and splenocytes were also extracted into single-cell suspension, and red blood cells were lyzed by <5 minutes of incubation in ammonium-chloride-potassium lysis buffer (Quality Biological, Gaithersburg, MD). Before surface staining, viability was determined by LIVE/DEAD staining according to the manufacturer's instructions (Molecular Probes, Eugene, OR). Cells were washed, and FcγRII/III was blocked with αCD16/32 mAb 93 (eBioscience, San Diego, CA). Surface markers were stained with fluorochrome-conjugated mAbs: CD11b mAb M1/70, CD45RB mAb C363-16A, Siglec F mAb E50-2440 (BD Biosciences, San Jose, CA); CD4 mAb RM4-5, CD8α mAb 53-6.7, CD54/ICAM1 mAb YN1/1.7.4, CD62L mAb MEL-14, CD64 mAb X54-5/7.1, CD183/CXCR3 mAb CXCR3-173, CD206/MφMR mAb C068C2, FcεRIα mAb MAR1, Ly6C mAb HK1.4, Ly6G mAb 1A8 (BioLegend, San Diego, CA); CD3ε mAb 145-2C11, CD44 mAb IM7, F4/80 mAb BM8, TCRβ mAb H57-597, TCRγδ mAb GL3 (eBioscience); CD45 mAb MCD4517, and CD45R/B220 mAb RA3-6B2. After washing, cells were fixed (BD Biosciences), or for intracellular, intranuclear staining with RORγt mAb Q31-378 (BD Biosciences), fixed and permeabilized with transcription factor-specialized buffers (eBioscience). Samples were acquired on a four laser custom LSR II cytometer running FACSDiva 6.0 (BD Immunocytometry, San Jose, CA). Data were analyzed with FlowJo version 10.8 (TreeStar Software, Ashland, OR).

Recall Stimulations

Superficial cervical LNs (scLNs) were resected, made into single-cell suspensions, and washed generously. LN cells (2 × 106) were plated in complete Dulbecco's modified Eagle's medium with 2.5 × 106 heat-killed S. aureus (InvivoGen, San Diego, CA). Supernatants were collected after 48 hours and stored at −80°C before interrogation by Linco multiplex cytokine assays (Millipore, Billerica, MA) or enzyme-linked immunosorbent assay (ELISA).

ELISA and Linco

Tissues were snap-frozen, stored at −80°C, homogenized in minimal essential medium (MEM) + 2% fetal bovine serum FBS, and stored at −80°C until used in ELISA or Linco assays. Homogenate cytokine levels were normalized to wet sample weights. Linco multiplex cytokine assays (Millipore) were used according to the manufacturer's instructions and acquired on a Luminex (Austin, TX) xMAP reader. Total serum IgG and IgE (BD Biosciences) and mouse myeloperoxidase (Abcam, Cambridge, MA) were determined by quantitative sandwich ELISA against standard curves, according to manufacturers' instructions.

Microbiology

Oral swabs were obtained with Copan eSwab kits and were subjected to broth-enrichment culture for Staphylococcus spp. as previously described.12 Isolates from these swabs were subjected to species identification and strain characterization by PCR.13, 14, 15, 16, 17 For in vitro killing assay, primary bone marrow neutrophils isolated by paramagnetic negative selection (Miltenyi Biotec) were co-cultured for up to 4 hours with live S. aureus at MOI = 1. Total colony counts of water-lyzed wells from each time point were plated for enumerating colony-forming units.

Statistical Analysis

Statistical analyses were performed on multiple group comparisons as described in the figure legends (GraphPad Prism version 6.0, San Diego, CA; StatPlus:mac Pro; AnalystSoft, Walnut, CA; Microsoft Excel 2016 version 15.24, Microsoft, Redmond, WA).

Results

IFNγRI−/−IL17RA−/− BALB/cJ Mice Develop Extensive Perioral Infection with S. aureus

We observed periocular blepharitis developing in our IL17RA−/− colony with varying penetrance, beginning at roughly 3 to 4 months of age (Figure 1, A and E). Similar phenotypes have been described in patients with defects in IL17RA or Act1.18, 19 Veterinary clinical calls from the Research Animal Resources division of Johns Hopkins University School of Medicine had alerted us to the presence of facial growths developing in our newly established IFNγRI−/−IL17RA−/− mouse colony (Figure 1, B–F).

Figure 1.

Figure 1

IFNγRI−/−IL17RA−/− mice develop spontaneous staphylococcal perioral abscesses. AD: Representative photography of disease phenotypes: periocular inflammation of IL17RA−/− BALB mice (A), and the perioral abscesses of IFNγRI−/−IL17RA−/− mice (BD). E and F: Gross pathologic examination of orbital (E) and oral (F) lesions in IFNγRI−/−IL17RA−/− mice and controls. Gross pathology was scored on a semiquantitative 0 to 4 scale. G and H: Body (G) and spleen (H) weight, expressed as a percentage of total body weight, at time of sacrifice. Statistics for discontinuous nonparametric data are by Kruskal-Wallis analysis of variance. I: Time course of disease onset, depicting gross oral pathology scores as a function of age at sacrifice. Regression lines for each genotype are color-coded as shown. J: Oral colonization of IFNγRI−/−IL17RA−/− mice and controls by Staphylococcus aureus, represented as CFUs of S. aureus from oral swabs. K: Semiquantitative real-time PCR of S. aureus sodA from oral tissue. Statistics are by one-way analysis of variance, followed by post hoc pairwise comparisons by Tukey-Kramer method. L and M: Quantitation of total serum immunoglobulins by sandwich ELISA. Individual mice are represented by diamonds or circles; means of groups by bars. Statistically significant pairwise comparisons are denoted between relevant groups. n = 21 IFNγRI−/−IL17RA−/− mice; n = 14 single-knockout IL17RA−/− mice; n = 14 IFNγRI−/− mice; n = 12 wild-type control mice (I). *P < 0.05, **P ≤ 0.01, and ***P ≤ 0.001. BW, body weight; CFU, colony-forming unit; ELISA, enzyme-linked immunosorbent assay; IFN, interferon.

Over time, the abscesses of IFNγRI−/−IL17RA−/− mice led to cachexia (Figure 1G), presumably because the abscesses interfered with normal feeding. IFNγRI−/−IL17RA−/− mice further demonstrated splenomegaly at the time of sacrifice compared with controls (Figure 1H), probably an indicator of their uncontrolled spontaneous infection. The time course of onset for the oral abscesses is depicted in Figure 1I. IFNγRI−/−IL17RA−/− mice began manifesting gross lesions between 6 to 10 weeks of age, increasing in severity over time. Comparing the slope of this regression with the control genotypes demonstrated significant progression of oral lesions in the IFNγRI−/−IL17RA−/− strain (P = 0.0015), in a manner not shared by the progression of the orbital lesions (not shown). At ages >20 weeks, abscesses were often severe enough to warrant euthanasia of IFNγRI−/−IL17RA−/− mice on consultation with veterinarians. Both male and female mice were affected with comparable incidence and severity (Supplemental Figure S1, A and B) and time course (not shown).

Methicillin-susceptible S. aureus was isolated and PCR-confirmed from the oral mucosa of nine of nine symptomatic mice tested (Figure 1J).12, 15 All isolates were negative for mecA/C, USA300, and luk-PV genes.16, 20 In a subset of three confirmed methicillin-susceptible S. aureus isolates selected for testing, all were scn positive and were spa-type t774. Although the identified strain did not match the dominant human community clone (PVL+ USA300) circulating in the United States, the presence of the scn gene in tested isolates indicates likely human origin and not a mouse-adapted strain.21 We further found expression of superoxide dismutase A (sodA) by quantitative real-time PCR from bulk genomic DNA in oral tissues (Figure 1K). Single-knockout IL17RA−/− and IFNγRI−/− controls, as well as wild-type mice, lacked similar pathology (Figure 1, E–K) (representative gross pathology for controls is not shown). Together, these data support that defects of both IFN-γ and IL-17 signaling pathways are essential contributors to the disease pathology of the IFNγRI−/−IL17RA−/− strain. Moreover, these pathways were collaborative in a manner in which their combined defect was sufficient for opportunistic infection.

We examined net Ig levels in the sera of these mice, as general markers of immune status, but more specifically, due to previous evidence of Th2 deviation in our investigations of IFNγ−/−IL17A−/− mice.1 By absolute quantitation through sandwich ELISA methods, we observed elevated serum IgG levels in IFNγRI−/−IL17RA−/− and IL17RA−/− mice (Figure 1L). However, quantitation of serum Ig demonstrated specific elevation of total IgE only in IFNγRI−/−IL17RA−/−mice (Figure 1M). From these data, we conclude that spontaneous staphylococcal infection of IFNγ−/−IL17A−/− mice recapitulates the susceptibility of hyper IgE patients to staphylococcal infection, possibly presenting a novel model of immunodeficiency processes in that disease.

Histopathologic Features of Infectious Lesions in IFNγRI−/−IL17RA−/− Mice

Histopathologic examination of oral tissues in control wild-type or IFNγRI−/− mice revealed no or limited oral inflammation (Figure 2, A, B, E and F). IL17RA−/− control mice, demonstrated signs of inflammation in the dermis that appeared to be consistent with folliculitis (Figure 2, C and G). The oral abscesses in IFNγRI−/−IL17RA−/− mice demonstrated extensive infiltration with mononuclear and polymorphonuclear cells, generally surrounding large heterogeneous eosin-staining material featuring large filamentous hematoxylin-staining inclusions (Figure 2, D and H). Generally, lesions appeared to be more associated with the oral mucosa of these tissues than the keratinaceous epidermal layers. Quantitative, subjective measurement of the histopathologic severity of these abscesses supported severely uncontrolled infection of oral tissues in IFNγRI−/−IL17RA−/− mice (Figure 2I).

Figure 2.

Figure 2

Histopathologic examination of abscesses of IFNγRI−/−IL17RA−/− mice reveals extensive surrounding polymorphonuclear infiltration. AH: Representative histopathology of perioral tissues from control genotypes and IFNγRI−/−IL17RA−/− mice. Boxed areas in AD correspond to higher-magnification images in EH. I: Scoring of histopathologic severity of perioral tissues. Individual mice are represented by diamonds or circles. Gram-staining of affected IFNγRI−/−IL17RA−/−perioral tissues by Brown & Brenn (JM) against hematoxylin and eosin serial sections (NP). Boxed area in J is enlarged in K; boxed areas in K are enlarged in L and M. Boxed area in N is enlarged in O; boxed area in O is enlarged in P. Statistics are by one-way analysis of variance, followed by post hoc pairwise comparisons by Tukey-Kramer method. Statistically significant pairwise comparisons are denoted between relevant groups. **P ≤ 0.01, ***P ≤ 0.001. Original magnification: ×10 (N); ×160 (O); ×640 (M and P). IFN, interferon.

Brown & Brenn Gram-staining of affected oral tissues in IFNγRI−/−IL17RA−/− mice revealed clusters of Gram-positive cocci deep within the abscess (Figure 2, J–L). These clusters also stained positive with Grocott's metheneamine silver (not shown). Serial section staining with H&E indicated these Gram-positive bacterial clusters were immediately bound by extensive polymorphonuclear and mononuclear inflammatory infiltrates (Figure 2, N–P). In addition, diffuse, isolated Gram-staining cocci could be seen elsewhere in the inflamed region (Figure 2M), further indicative of insufficient control of bacterial invasion and outgrowth in the oral mucosa of IFNγRI−/−IL17RA−/− mice.

We expanded our histopathologic analysis to other tissues, to determine whether staphylococcal infection had trafficked to other tissues or become systemic. We did not observe clear signs of disseminated infection in lung, liver, or spleen (Supplemental Figure S1, C–G). In mice with highly advanced severe oral lesions, we observed limited periportal hepatic inflammatory foci (Supplemental Figure S1, C and D) and pyogranulomatous infiltrates in lung (Supplemental Figure S1G). These signs of advancing systemic inflammation or disseminating infection generally appeared only in older mice with more severe oral pathology. We interpreted the involvement of these organs as spillover from severe oral infections.

In addition to the perioral lesions, we also observed smaller purulent abscesses developing in the forelimbs of IFNγRI−/−IL17RA−/− mice (Supplemental Figure S1, H–M) and none of the control genotypes (not shown). Generally, these forelimb manifestations were not as prevalent, appearing largely in older mice with more severe perioral abscesses. Forelimb abscesses were often bilateral, but not necessarily symmetric. Histopathologic examination revealed Gram-positive abscesses developed in the subdermis, without invasion into the underlying musculoskeletal structures or synovia. It should also be noted that these lesions do not appear in our colony of IFNγ−/−IL17A−/− mice,1 indicating that an IL-17 family member other than IL-17A is the necessary ligand in native defense to S. aureus invasion in the oral mucosa.

Cellular Mediators of Staphylococcal Lesions in IFNγRI−/−IL17RA−/− Mice: Compromised Neutrophil Function in the Absence of IL-17 Signaling

We used cytometric methods to interrogate the infiltrate of affected perioral tissues, with particular attention toward effector populations. Clear infiltration of these tissues by CD45+ leukocytes was evident in IFNγRI−/−IL17RA−/− mice (Figure 3A). Consistent with histopathologic data, there was also evidence of mild inflammatory infiltration of perioral tissues in IL17RA−/− mice, although not to the extreme degree of IFNγRI−/−IL17RA−/− mice.

Figure 3.

Figure 3

Defects in neutrophils as cellular mediators of host defense to Staphylococcus aureus in oral tissues of IFNγRI−/−IL17RA−/− mice. A: Total oral CD45+ leukocytes, expressed as absolute numbers, normalized to sample weight. BD: Ly6GhiCD11b+ neutrophils (B), Siglec F+Ly6Gint eosinophils (C), and FcεRIα+ mast cells and basophils (D) infiltrating oral tissues expressed as absolute numbers, normalized to sample weight. EH: Representative bivariate plots of viable CD45+-gated events in oral tissues depict concatenates of each group. I and J: Myeloperoxidase levels in perioral tissue homogenates by quantitative sandwich ELISA, normalized by sample weight (I), and in ratio to total neutrophil counts from Figure 3B (J). Statistics are by Fisher's LSD. K:In vitro killing of S. aureus by neutrophils. Individual mice are represented by diamonds or circles; means of groups by bars. Statistically significant pairwise comparisons are denoted between relevant groups. *P < 0.05, **P ≤ 0.01, and ***P ≤ 0.001. ELISA, enzyme-linked immunosorbent assay; IFN, interferon; LSD, least significant difference; MPO, myeloperoxidase.

By far, the most abundant infiltrating leukocyte was Ly6Ghi neutrophils (Figure 3B), consistent with the extensive polymorphonuclear infiltrates observable by histopathology. Other granuloid cell types, including Siglec F+ eosinophils (Figure 3C) and FcεRIα+ mast cells and basophils (Figure 3D), were also elevated in the affected oral tissues of IFNγRI−/−IL17RA−/− mice, although not to the same extreme degree as neutrophils and not significantly in comparison with IL17RA−/− controls.

The extensive neutrophil infiltration of infected oral tissues of IFNγRI−/−IL17RA−/− mice was at odds with well-described roles for neutrophils in control of experimental infection with S. aureus.6, 22 The abundance of neutrophils despite ongoing infection suggested functional defects (Figure 3, E–H). To address the role of neutrophils in native oral defense to S. aureus, IFNγRI−/− mice were depleted of neutrophils by extended treatment over 4 weeks with the mAb 1A8. At the end of this neutrophil depletion course, mild subdermal inflammation was observed (Supplemental Figure S2), resembling the mild inflammation observed in IL17RA−/− controls.

As an indicator of neutrophil function in the affected perioral tissues, we interrogated homogenates of cheek tissues by quantitative sandwich ELISA for the canonical neutrophil granule product myeloperoxidase (MPO). Like many of the other cytokine analytes (Supplemental Figure S3), MPO levels were highest in IFNγRI−/−IL17RA−/− mice (Figure 3I), a probable indicator of persistent infection. These data were normalized to sample weight, similar to the cytometric analyses presented in Figure 3B. Because of this common normalization factor, we could approximate a ratio of MPO levels to neutrophil numbers—as an indicator of how much MPO each neutrophil might be producing in situ. From this calculation, we observed diminished per-cell equivalents of MPO in the oral tissues of IFNγRI−/−IL17RA−/− and IL17RA−/− mice (Figure 3J). Experimental in vitro co-culture assays with live S. aureus (Figure 3K) did not demonstrate defective killing with IFNγRI−/−IL17RA−/− bone marrow neutrophils. Altogether, these data support that IL-17 signaling predominates control of neutrophilic recruitment and function in host defense to Staphylococcus.

Cytokine and Chemokine Mediators of Staphylococcal Lesions in IFNγRI−/−IL17RA−/− Mice

Neutrophil recruitment is a canonical function for IL-17 signaling, but it fails to explain the involvement of IFN-γ in defense against Staphylococcus, or why IFNγRI−/−IL17RA−/− mice progress to uncontrolled infection. To better understand the mechanism underlying the failure of IFNγRI−/−IL17RA−/− mice to control staphylococcal infection, we examined the expression of various cytokine and chemokine mediators by interrogating homogenates of perioral tissues by multiplex cytokine array. By and large, most cytokine analytes were highest in the IFNγRI−/−IL17RA−/− mice (Supplemental Figure S3), compared with single-knockout and wild-type controls, which we interpret to be a response to ongoing infection.

Grouping these analytes functionally, we observed increased levels of the proinflammatory cytokines IL-1β, IL-6, and tumor necrosis factor-α specifically in IFNγRI−/−IL17RA−/− mice (Supplemental Figure S3, A–C). Similarly, we observed production of the neutrophilic chemokine CXCL1/KC, and the neutrophil growth factors granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in the affected perioral tissues of IFNγRI−/−IL17RA−/− mice (Supplemental Figure S3, D–F). Interestingly, we observed increased expression of IL-17A in both the single-knockout IL17RA−/− and double-knockout IFNγRI−/−IL17RA−/− strains, suggesting compensatory overexpression in the absence of IL-17 signaling (not shown). We further observed increased expression of chemokines associated with monocyte and macrophage recruitment, including chemokine ligand (CCL)2, CCL3, and CCL5 (Supplemental Figure S3, G–I).

In studies in autoimmune heart disease, we found that dual deletion of the cytokine ligands IFN-γ and IL-17A led to Th2 deviation.1 Interrogating Th2-associated cytokines in the perioral tissues of IFNγRI−/−IL17RA−/− mice, we observed increased production of IL-4, IL-10, and a trend for CCL11/eotaxin-1 (Supplemental Figure S3, J–L), but no appreciable levels of IL-5 or IL-13 (not shown).

To make functional sense of these data, we further conceptually reorganized analytes according to one of four patterns of expression, depending on their correlation to genotype. Largely, most analytes interrogated demonstrated highest production in IFNγRI−/−IL17RA−/− mice, a finding we interpret to signify ongoing infection of these mice. A second grouping of cytokines and chemokines were elevated in both double-knockout and IL17RA−/− mice, including CCL2/monocyte chemoattractant protein-1, CCL5/regulated on activation normal T cell expressed and secreted, CXCL10/IFN-γ–induced protein 10, and IL-17A. We interpret IFNγRI−/−IL17RA−/− mice tracking alongside the IL17RA−/− strain to indicate that expression of these cytokines was under the predominant control of IL-17 signaling. A fewer number of analytes, exemplified by granulocyte-macrophage CSF, tracked with the IFNγRI−/− single-knockout control.

However, only one chemokine demonstrated lower levels specifically in IFNγRI−/−IL17RA−/− mice, compared with control strains: CXCL9/Mig (Figure 4A), implicating this chemokine in functional control of mucosal S. aureus. The similarly regulated chemokine CXCL10/IFN-γ–induced protein 10 did not demonstrate this pattern (Figure 4B). As further confirmation, we observed a similar defect in CXCL9/Mig production in the supernatants of lymphocytes from the scLNs, restimulated with heat-killed S. aureus (Figure 4C).

Figure 4.

Figure 4

Lymphoid mediators of host defense to Staphylococcus aureus in IFNγRI−/−IL17RA−/− mice and control strains. AC: CXCL9 (A) and CXCL10 (B) interrogated by Linco 32-plex xMAP array from homogenates of oral tissues, normalized to sample weight; and supernatants from lymphocytes from the superficial cervical LN, restimulated with heat-killed S. aureus (C). D: Total counts of viable CD45+ cells from scLN. EL: CXCR3 expression on scLN T-cell populations, as viable CD45+ lymphocyte-gated cells from wild-type BALB/c mice in representative bivariate plots (EH) and expressed as a proportion of parent populations, including total CD4+TCRβ+ cells (I and J) and γδ+ T cells (K and L). Red arrows denote gated populations. M and N: Total CD4+ (M) and γδ T (N) cells infiltrating oral tissues, expressed as absolute numbers, normalized to sample weight. OV: Representative bivariate plots depict concatenates of each group, as a proportion of viable CD45+ lymphocytes. Regions shaded in red depict double-positive populations. Statistics are by one-way analysis of variance, followed by post hoc pairwise comparisons by Tukey-Kramer method. Statistically significant pairwise comparisons are denoted between relevant groups. *P < 0.05, **P ≤ 0.01, and ***P ≤ 0.001. IFN, interferon; scLN, superficial cervical lymph node; TCR, T-cell receptor.

Cellular Mediators of Staphylococcal Lesions: Defects of T-Cell Programing and Recruitment

In addition to the splenomegaly in IFNγRI−/−IL17RA−/− mice described above, we further observed lymphadenopathy, specifically in the scLNs (Figure 4D). Enumerating total numbers of lymphocytes, we observed expansion of all lymphoid subpopulations in the draining LNs of IFNγRI−/−IL17RA−/− mice (Supplemental Figure S4, A–D), again, a likely signifier of persistent infection.

We took particular note of relatively greater expansion among γδ T cells in the LN, because these cells were increased to a greater degree in IFNγRI−/−IL17RA−/− mice than other T-cell populations; scLN γδ T cells in IFNγRI−/−IL17RA−/− mice were expanded 24-fold over wild-type mice, compared with <10-fold expansions for CD4+ and CD8+ T cells. Cutaneous γδ T cells have been shown to be critical sources of IL-17 in response to experimental S. aureus infection.5 Moreover, we found dramatic expansion of γδ T cells bearing signs of activation, effector, and memory differentiation in the scLNs of IFNγRI−/−IL17RA−/− mice compared with controls, more so than in CD4+ αβ T cells in these mice (Supplemental Figure S4, E–N), further supporting that the γδ T cell lineage is more central to antistaphylococcal responses.

Defective expression of CXCL9 led us to examine the expression of its receptor, CXCR3, on lymphocytes in the scLNs, with particular regard for their activation and memory status by using the marker CD45RB (Figure 4, E–H). CXCR3 expression among CD4+ T cells was highest on CD45RBlo cells, consistent with published reports (Figure 4, H–J).23, 24, 25 In contrast, among γδ T cells, CD45RBhi cells expressed CXCR3, whereas CD45RBlo cells did not (Figure 4, F, K and L). These data indicated that in contrast to CD4+ T cells, which acquire CXCR3 expression on activation and memory differentiation, oral γδ T cells express CXCR3 in the naive state and lose it in the effector differentiation process.

Comparing CXCR3 expression across genotypes, we observed fewer CD4+CD45RBlo and TCRγδ+CD45RBhi T cells expressing CXCR3 in the scLNs of IFNγRI−/−IL17RA−/− mice (Figure 4, J and K). Together with the CXCL9 data, these findings suggested that CXCL9/CXCR3-mediated recruitment of CD4+ and γδ T cells to the affected perioral tissues may be disrupted (Figure 4, M–V). Absolute enumeration of these subsets, presented in Figure 4, M and N, demonstrated that total numbers of CD4+ and γδ T cells were not elevated in IFNγRI−/−IL17RA−/− mice, compared with IL17RA−/− single-knockout controls. Moreover, the frequency of γδ T cells infiltrating oral tissues was diminished in the IFNγRI−/−IL17RA−/− strain, compared with the IL17RA−/− control (Figure 4V). From this pattern of recruitment, we conclude that in the absence of IFN-γ–dependent CXCL9 signaling, recruitment of CD4+ and γδ T cells to oral tissues is blunted in IFNγRI−/−IL17RA−/− mice.

Cellular Mediators of Staphylococcal Lesions: Compromised Macrophage Function in the Absence of IFN-γ Signaling

Examining the numerous canonical functions ascribed to IFN-γ signaling, among the best studied involve the activation of antimicrobial effector immunity in macrophages and monocytes.26 In what is now termed classic or M1 activation of macrophages, IFN-γ up-regulates nitric oxide production, antigen presentation and costimulation, and proinflammatory cytokine expression.27 In addition, chemokines downstream of both IFN-γ and IL-17 signaling are known chemotactic factors for heterogeneous monocytic precursors, in association with divergent functionality among monocyte subpopulations.28

Numerically, we observed recruitment of all myeloid subsets: F4/80+ macrophages, Ly6Chi inflammatory monocytes, and Ly6Clo resident monocytes into the affected perioral tissues of IFNγRI−/−IL17RA−/− mice (Figure 5, A–C). However, if these data were analyzed as a proportion of CD11b+Ly6G cells, to examine the relative balance of recruitment and differentiation of these subpopulations, several differences emerge. Proportions of F4/80+ macrophages were diminished in IFNγRI−/−IL17RA−/− and IL17RA−/− mice (Figure 5D); similar defects were not observed in spleen (not shown), suggesting that IL-17 signaling contributes to monocyte-to-macrophage differentiation in situ. Moreover, the proportions of Ly6ChiF4/80lo inflammatory monocytes were diminished in IFNγRI−/−IL17RA−/− and IFNγRI−/− mice (Figure 5, E and G–J), and Ly6Clo resident monocytes were elevated in IFNγRI−/−IL17RA−/− mice (Figure 5, F–J). We have observed similar diminution of Ly6Chi monocytes and expansion of Ly6Clo monocytes in the draining LNs (not shown), but not spleen (not shown), indicating this population shift may be a specific recruitment defect in affected tissues. Taken together, these data indicate that IFN-γ and IL-17 signaling collaborated in controlling the balance of differential monocyte recruitment to infected oral tissues.

Figure 5.

Figure 5

Macrophage function in host defense to Staphylococcus aureus in IFNγRI−/−IL17RA−/− mice. AC: Total F4/80+CD11b+Ly6G macrophages (A), Ly6ChiF4/80loCD11b+Ly6G monocytes (B), and Ly6CloF4/80loCD11b+Ly6G monocytes (C) in oral tissues expressed as absolute numbers, normalized to sample weight. DF: Proportions of oral macrophages and monocytes, expressed as percentiles of CD11b+Ly6G events. All cells are gated on viable CD45+ events. GJ: Representative bivariate plots depict concatenated groups gated on viable CD11b+Ly6GCD45+ events. KM: Macrophage polarization indicated by expression of CD54/ICAM1 and/or CD206/MφMR, expressed as a proportion of viable CD64+F4/80+CD11b+Ly6GCD11cCD45+ events. Individual mice are represented by diamonds or circles; means of groups by bars. Statistics are by one-way analysis of variance, followed by post hoc pairwise comparisons by Tukey-Kramer method. Statistically significant pairwise comparisons are denoted between relevant groups. *P < 0.05, **P ≤ 0.01, and ***P ≤ 0.001. ICAM, intercellular adhesion molecule 1; IFN, interferon; MφMR, macrophage mannose receptor.

We further examined the in situ expression of markers associated with classic M1 and alternative M2 activation of macrophages—CD54/intercellular adhesion molecule-1 (ICAM1) and the macrophage mannose receptor (CD206, MφMR), respectively. CD64+F4/80+ macrophages from the cheek were digested and stained for these markers. A greater proportion of macrophages in the oral tissues of GRAKO mice coexpressed ICAM1 and CD206/MφMR (Figure 5K). Comparing single-positive macrophage subpopulations, a smaller proportion of macrophages expressed ICAM1, compared with IL17RA−/− mice (Figure 5L), consistent with defective M1 activation. We also observed defective expression of an M2-like CD206/MφMR+ phenotype in IFNγRI−/−IL17RA−/− and IL17RA−/− mice (Figure 5M), indicating that IFN-γ and IL-17 signaling also colluded in driving polarization of macrophage effector phenotypes in oral tissues.

To experimentally address the role of macrophages in the collaboration of IFN-γ and IL-17 signaling, we depleted macrophages in vivo from IL17RA−/− mice, proceeding from the hypothesis that the major function of IFN-γ signaling in this system was to promote local recruitment and activation of the macrophage lineage in response to S. aureus. To accomplish this, we treated mice with liposomes loaded with low-dose clodronate, an approach that selectively targets cells of the MPS lineage for phagocytic uptake-mediated depletion (Figure 6, A and B).29 In both clodronate liposome and control groups, we observed progression of blepharitis lesions, consistent with the IL17RA−/− background (Figure 6, C and E). However, in macrophage-depleted mice, we observed recapitulation of the oral lesions observed in IFNγRI−/−IL17RA−/− mice (Figure 6, D–I), splenomegaly (Figure 6G), and outgrowth of S. aureus in the oral habitat (Figure 6J). Histopathologic examination of oral tissues from clodronate liposome-treated mice confirmed the presence of Gram-positive cocci in these abscesses (Figure 6, K–P). These data strikingly corroborated our hypothesis that MPS-lineage cells were an important collaborator with IL-17–dependent defense to Staphylococcus in the oral mucosa. Moreover, these data were consistent with these MPS-lineage cells being critical signaling targets of IFN-γ.

Figure 6.

Figure 6

Macrophages are critical collaborators with IL-17–directed responses to Staphylococcus aureus in the oral mucosa. Data are representative of two independent experiments. A and B: Depletion of macrophages from oral tissues of IL17RA−/− mice by treatment with clodronate-loaded liposomes; representative bivariate plots represent concatenated pools at day 10 of treatment. C and D: Progression of orbital (C) and oral (D) abscesses in IL17RA−/− mice depleted of macrophages by treatment with clodronate-loaded liposomes (red). Control IL17RA−/− mice (gray) were untreated or administered PBS-loaded liposomes. EG: Gross pathology of orbital (E) and oral abscesses (F), splenomegaly in IL17RA−/− mice after 5 weeks of macrophage depletion (G). H and I: Representative gross oral pathologic lesions in IL17RA−/− mice after 5 weeks of macrophage depletion. J: Oral colonization of macrophage-depleted IL17RA−/− mice and controls by S. aureus, represented as CFUs of S. aureus from oral swabs at week 5 of treatment. KP: Histopathologic evaluation of oral abscesses in macrophage-depleted IL17RA−/− mice (K) and representative histopathology of oral lesions from control (L and M) or clodronate liposome-treated (NP) mice. Boxed area in N is enlarged in O and P. QT: Expression of CXCR3 on CD4+ (Q and R) and γδ T cells (S and T) in the scLN of macrophage-depleted IL17RA−/− mice. Representative bivariate plots depict concatenates of groups, or individual mice. All cells are gated on viable CD45+ events. Individual mice are represented by diamonds or circles; means of groups by bars. Statistics are by one-way analysis of variance, followed by post hoc pairwise comparisons by Tukey-Kramer method. Statistically significant pairwise comparisons are denoted between relevant groups. n = 5 untreated control IL17RA−/− mice; n = 5 control IL17RA−/− mice administered PBS-loaded liposomes (C and D). *P < 0.05, **P ≤ 0.01. CFU, colony-forming unit; H&E, hematoxylin and eosin; lip, liposome; PBS, phosphate-buffered saline; scLN, superficial cervical lymph node.

We further examined the effector and memory differentiation of T cells in the draining LN. Although dendritic cells are thought to be major producers of CXCL9, this chemokine has also been reported from cell types in the monocyte/macrophage lineage, particularly in the gastrointestinal mucosa.30, 31, 32, 33 This led us to hypothesize that defective recruitment and activation of monocytes and macrophages may be responsible for the defect in CXCL9/CXCR3-mediated recruitment of T cells described above. To address this, we assessed local T cell phenotypes from clodronate-liposome–treated mice. Fewer CD45RBloCD4+ memory T cells and CD45RBhiTCRγδ+ cells in the scLNs of macrophage-depleted IL17RA−/− expressed CXCR3, compared with control phosphate-buffered saline-liposome–treated mice (Figure 6, Q–T), also phenotypically mimicking the T-cell recruitment defects observed in GRAKO mice. From this, we conclude that oral macrophages support recruitment of T cells to the infected oral mucosa.

Discussion

We describe here a novel, emergent model of spontaneous Staphylococcus aureus infection of the skin and oral mucosa in IFNγRI−/−IL17RA−/− mice. Previously studied in isolation, this is the first demonstration to our knowledge that the archetypic effector cytokines of the Th1 and Th17 programs collaborate in mucosal host defense to S. aureus.5, 6, 7 Investigating these mechanisms in situ has revealed coordination of IL-17–driven neutrophils, and IFN-γ–dependent macrophages in controlling invasion and infection with S. aureus in the oral mucosa.

Our data support IL-17 signaling pathways and effector responses occupying a more central position in defense to S. aureus. In our animal facility at Johns Hopkins University, IL17RA−/− mice develop low-level inflammation of the facial mucosa, including blepharitis, folliculitis, elevated serum IgG, localized lymphadenopathy, oral infiltration with neutrophils, CD4+ T-cell activation, maturation of dendritic and B cells (not shown), and oral expression of selected cytokines. Spontaneous mucocutaneous staphylococcal infections have been reported in some animal colonies deficient in IL-17 signaling.34, 35 Because of no small part to environmental factors and background genetics, it is unclear how severe and replicable these other models are in direct comparison with IFNγRI−/−IL17RA−/− mice. In addition to folliculitis, we observe some signs of limited abscess development in roughly one-quarter of IL17RA−/− mice, but with less incidence and severity than in the GRAKO colony.

The IL17RA receptor subunit is thought to be a common signaling transducer for all members of the IL-17 family.36, 37 Critical roles for IL-17A in defense to experimental skin infection with S. aureus have been described5, 38; however, we have not observed oral abscesses in our colony of IFNγ−/−IL17A−/− mice (data not shown), deficient in cytokine ligands rather than receptors, underscoring that IL-17A is not the critical IL-17 family member in this mucocutaneous disease process. Candidate alternative IL-17 family members include IL-17C and IL-17F.35, 39

Part of the original description of Th17 cells as a unique and separate lineage underscored that IL-23, rather than IL-12, signaling was critical for the differentiation of these cells.40 Moreover, Th1 programing suppressed the differentiation of Th17 cells, in a manner analogous to the mutual countersuppression of the Th1 and Th2 lineages.41, 42 It has since become clearer that there exist more complex relations between the Th1 and Th17 programs. Coexpression of IFN-γ and IL-17 had been reported in some of the earliest characterizations of the Th17 program.43, 44, 45 The development of fluorescent reporter strains for tracking Th17 cell fating further demonstrated clear plasticity among these lineages; a sizable fraction of Th17 cells convert into IFN-γ–producing cells in pathogenic circumstances, including infection and autoimmune disease.46 Moreover, although IL-17 production remains archetypally definitive for the Th17 lineage, it is also clear that other inflammatory cytokines can be elicited from Th17 cells, including IL-6, IL-17F, IL-22, and granulocyte-macrophage CSF.47, 48

IL-17–driven neutrophilic responses have been reported to be a hallmark of host defense to an experimentally induced model of S. aureus infection in cutaneous tissues.4 The cytokines IL-1β and IL-17A are critically important in establishing a positive feedback conduit between responding neutrophils and T cells in controlling S. aureus.5, 6 Defects in components of these signaling pathways, their upstream triggers, and downstream effectors are associated with susceptibility to S. aureus. Such critical pathways include myeloid differentiation primary response gene 88 and IL-1 receptor-associated kinase-4,49, 50, 51 as well as defects in granulopoiesis.52, 53 We found highly neutrophilic infiltration into the oral tissues of IFNγRI−/−IL17RA−/− mice, indicating there was no defect in neutrophil recruitment in these mice. Instead, we interrogated tissue MPO, as an in situ surrogate marker for neutrophil function in vivo, finding diminished estimated per-cell levels of tissue MPO. Additional microbicidal functions were not interrogated, retaining the possibility that other neutrophil antimicrobial pathways were unaffected.54 In vitro, we did not observe defective S. aureus killing by IFNγRI−/−IL17RA−/− neutrophils, emphasizing the likelihood of an additional cellular partner being required to observe defective antimicrobial function in IFNγRI−/−IL17RA−/− mice.

Altogether, our findings are consistent with these reports. In our mouse cohorts, IFN-γ pathways seemed to be lesser contributors than those mediated by IL-17 in the disease of IFNγRI−/−IL17RA−/− mice; IFNγRI−/− control mice appeared more phenotypically normal than IFNγRI−/−IL17RA−/− or IL17RA−/− mice. From this, we conclude that IL-17, rather than IFN-γ, was critical for initial barrier defenses. However, an IFN-γ–dependent mechanism was important as a collaborative secondary defense in the failure of IL-17–dependent protection. This contribution of IFN-γ to this collaborative mechanism was of great interest, especially given disagreement as to the role of IFN-γ in defense to S. aureus. Blockade of IFN-γ protected animals from death after high-dose systemic infection with S. aureus.7 Similarly, survival of IFNγ−/− or IFNγRI−/− mice was improved after i.v. S. aureus infection.8, 10 From these data, these researchers ascribed pathogenic roles for IFN-γ in response to S. aureus; although it should be noted that these findings precede the discovery of the Th17 lineage.

Of the numerous pleiotropic effects driven by IFN-γ, among the best studied include the classic activation of macrophages in which IFN-γ drives a potent antimicrobial program, including nitric oxide and superoxide production, as well as lysosomal maturation.27, 55 Bactericidal macrophage functions have been investigated in defense to S. aureus, with particular regard for the potential of S. aureus to persist in macrophage endocytic compartments.56, 57, 58, 59 The effectiveness of antistaphylococcal macrophage bactericidal activity in vitro was enhanced by IFN-γ signaling.60 These data point to a role for IFN-γ–dependent macrophage differentiation in defense to S. aureus. To test this hypothesis, we depleted monocytes and macrophages in vivo from IL17RA−/− mice using clodronate-loaded liposomes.29 This treatment elicited oral abscesses, recapitulating the disease of GRAKO mice, which has not been true of other models in which we have applied this strategy of macrophage depletion.61 From this, we conclude that macrophages are an important collaborator with IL-17–dependent defenses to S. aureus.

In addition to effects on macrophages, a role has been reported for IFN-γ in amnestic recall responses to S. aureus.9 Our data indicate that IFN-γ was critically important in driving CXCL9 expression in response to S. aureus in infected oral tissues. CXCL9 is among several chemokines expressed under the control of IFN-γ.62, 63 Among these, CXCL9 was the only analyte for which we observed defective expression in the GRAKO strain. CXCL9 expression has been reported in response to pulmonary infection with S. aureus.64 The cognate receptor for CXCL9, CXCR3, is expressed on T cells undergoing memory and effector differentiation.65, 66 In addition to diminished expression of CXCR3 on T cells, we further found limited recruitment of T cells to oral tissues in GRAKO mice. Together, these data indicate that in response to S. aureus, IFN-γ directed CXCL9 expression, which in turn drove recruitment of T cells to affected oral tissues. Furthermore, we found that macrophage depletion mimicked the defects in recruitment of CXCR3+ T cells observed in GRAKO mice. From this, we further conclude that IFN-γ–driven M1 polarization supports a positive feedback circuit between macrophages and responding T cells through CXCL9/CXCR3 signaling.

In this data set, we also observed some signs of Th2 deviation, including elevated local production of IL-4 and CCL11/eotaxin, and elevated serum IgE. However, we did not observe substantial elevations of tissue infiltration with eosinophils or cells of the basophil/mast cell lineage. Moreover, intracellular staining did not demonstrate increased frequencies of IL-4–producing T cells in the LNs of affected IFNγ−/−IL17A−/− mice (not shown). We take these data to indicate that IFNγRI−/−IL17RA−/− mice do not undergo a canonical Th2 deviation at a clonal level, that elevated IL-4 and CCL11 levels are indicative of the ongoing response to chronic infection, at a scale comparable with numerous other inflammatory cytokines and chemokines. Put another way, there is not sufficient evidence to support Th2 deviation being the sole or primary instigator of disease in IFNγ−/−IL17A−/− mice. In experimental infection models, roles for Th2 cytokines have been proposed as contributors to staphylococcal clearance.8

Roles for both IFN-γ and IL-17 signaling, and associated pathways, have been reported in human staphylococcal infections. In patients, inflammatory and immunodeficiency disorders are important factors determining host susceptibility to staphylococcal infection.2 Among the discrete immunodeficiencies associated with staphylococcal opportunism, hyper IgE syndrome (HIES) represents clusters of mutations in the inflammatory cytokine signal transducer and transcription factor STAT3; defective IL-17–centered immunity underpins much of the susceptibility to infection in HIES.67, 68, 69, 70 Several groups have reported defective IFN-γ production capacity in peripheral blood mononuclear cells from HIES patients, with particular regard for explicating the elevations of IgE production that are pathognomic for the disease.71, 72, 73 Here, we report that IFNγRI−/−IL17RA−/− mice phenocopy the pathognomic laboratory finding of drastically elevated serum IgE in HIES patients; IFNγRI−/−IL17RA−/− mice had on average >100 times the levels of circulating IgE, in comparison with wild-type control mice. From these data, we conclude the disease of IFNγRI−/−IL17RA−/− mice recapitulates the susceptibility of HIES patients to staphylococcal infection.

From our findings, we propose the following model: IL-17 signaling is required for initial barrier defense to S. aureus through controlling local neutrophil recruitment in a manner that feeds back to IL-17 production by CD4+ and γδ T cells via IL-1β production. In the oral mucosa, this IL-17 family member is not IL-17A. Disruption of this circuit enables opportunistic staphylococcal colonization of the oral mucosa. IFN-γ–dependent mechanisms serve as a secondary defense, enabling local macrophage differentiation and activation, as well as recruiting activated or memory lymphocytes via CXCL9/Mig. Moreover, these IFN-γ–mediated effects require collaborative synergy with IL-17–driven neutrophilic defenses for maximal effectiveness. Collaborative recognition of neutrophil extracellular traps by macrophages have been demonstrated to be important in clearance of S. aureus in vitro.74 Moreover, IFN-γ–driven macrophages form a positive feedback circuit, assisting in the recruitment of T cells through CXCL9 expression. Other functional defects in the host response to S. aureus seem likely to also be occurring, and need not be exclusive with the mechanisms proposed here.

Acknowledgments

We thank Amgen and Dr. Jay Kolls (University of Pittsburgh) for their generous provision of IL17RA−/− BALB/c founder mice; Cory Brayton and Zachary Freeman (Johns Hopkins University School of Medicine Phenotyping Core) for assistance with initial characterization of IFNγRI−/−IL17RA−/− mice; Xiaoling Zhang (Johns Hopkins University School of Medicine Analytic Cytometry Core); Shanna Ludwig for expert assistance with quantitative microbiology; the editors for helpful suggestions and formatting the figures; and Norman J. Barker (Pathology Photography and Graphic Arts Laboratory, Johns Hopkins University School of Medicine) for expert assistance with photomicrography.

Footnotes

Supported by NIH National Heart, Lung, and Blood Institute grants R01HL118183 (D.C.) and R01HL113008 (D.C.), the Gilead Sciences Research Scholars program (J.G.B.), and the American Autoimmune-Related Diseases Association (J.G.B.). N.L.D. is supported by predoctoral fellowship 15PRE25400010 from the American Heart Association and the Richard J. and Margaret Conn Himelfarb Student Support Fund. X.H. is the O'Leary-Wilson Fellow in Autoimmune Disease Research at the Johns Hopkins Autoimmune Disease Research Center.

Disclosures: Amgen provided IL17RA−/− BALB/c founder mice.

Supplemental material for this article can be found at http://dx.doi.org/10.1016/j.ajpath.2016.07.001.

Supplemental Data

Supplemental Figure S1.

Supplemental Figure S1

A and B: Comparison of gross pathologic lesions of male and female IFNγRI−/−IL17RA−/− mice. CG: Histopathologic characterization of additional disease phenotype in highly affected IFNγRI−/−IL17RA−/− mice. Subject was a 15-week-old IFNγRI−/−IL17RA−/−male mouse, with a grade 3 oral lesion. Note the limited periportal inflammatory foci in liver and pyogranulomatous inflammatory infiltration in lung. D shows an enlargement of the boxed area in C. HM: Development of abscesses in forelimbs of IFNγRI−/−IL17RA−/− mice, including representative histopathology. K and M show enlarged sections of J and L, respectively. Statistics are by U-test (NS). Original magnification, ×10 (J–M). IFN, interferon; NS, not significant.

Supplemental Figure S2.

Supplemental Figure S2

Neutrophil depletion from IFNγRI−/− mice. AD: Cytometric enumeration for Ly6GhiCD11b+ neutrophils, gated on viable CD45+ events, from spleen and oral tissues. Representative bivariate plots depict concatenates of each group. E and F: Body weight (E) and spleen weight (F) (as a percentile of body weight). G: Oral colonization by Staphylococcus aureus, represented as CFUs of S. aureus from oral swabs. HJ: Scoring of histopathologic severity of perioral tissues (H) and representative histopathology (I and J), depicting the median of each group. Individual mice are represented by diamonds or circles; means of groups by bars. Statistics are by two-tailed Student's t-test. Statistically significant pairwise comparisons are denoted between relevant groups. *P < 0.05, ***P ≤ 0.001. Original magnification, ×400. CFU, colony-forming unit; IFN, interferon.

Supplemental Figure S3.

Supplemental Figure S3

Cytokine and chemokine mediators of host defense to Staphylococcus aureus in IFNγRI−/−IL17RA−/−, IL17RA−/−, IFNγRI−/−, and wild-type mice. AL: Cytokines and chemokines were interrogated by Linco 32-plex xMAP array from homogenates of oral tissues, organized here as functional groupings. Data are expressed as means ± SD of groups of individual mice normalized to sample weight. Statistics are by one-way analysis of variance, followed by Fisher's LSD. Statistically significant pairwise comparisons are denoted between relevant groups. n = 5 IFNγRI−/−IL17RA−/− mice; n = 4 IL17RA−/− mice; n = 5, IFNγRI−/− mice; n = 5 wild-type mice. *P < 0.05, **P ≤ 0.01, and ***P ≤ 0.001. CCL, chemokine ligand; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; LSD, least significant difference; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; RANTES, regulated on activation normal T cell expressed and secreted; TNF, tumor necrosis factor.

Supplemental Figure S4.

Supplemental Figure S4

Extended phenotypic analysis of lymphocytes in the draining sublingual superficial cervical lymph nodes of IFNγRI−/−IL17RA−/− mice. AD: Enumeration of lymphocyte populations in the scLN. EJ: Activation, memory, and effector differentiation among CD4+TCRβ+ (EG) and TCRγδ+ T cells (HJ) in the scLN, expressed as percentiles of parent population. KN: Coordinate expression of RORγt and CD45RB on TCRγδ+-gated scLN T cells. Individual mice are represented by diamonds or circles; means of groups by bars. Representative bivariate plots depict concatenated groups. Statistics are by one-way analysis of variance, followed by Bonferroni post-testing. Statistically significant pairwise comparisons are denoted between relevant groups. *P < 0.05, **P ≤ 0.01, and ***P ≤ 0.001. IFN, interferon; RORγt; retinoic acid receptor (RAR)-related orphan receptor γ thymus-specific isoform; scLN, superficial cervical lymph node; TCR, T-cell receptor.

References

  • 1.Barin J.G., Baldeviano G.C., Talor M.V., Wu L., Ong S., Fairweather D., Bedja D., Stickel N.R., Fontes J.A., Cardamone A.B., Zheng D., Gabrielson K.L., Rose N.R., Cihakova D. Fatal eosinophilic myocarditis develops in the absence of IFN-gamma and IL-17A. J Immunol. 2013;191:4038–4047. doi: 10.4049/jimmunol.1301282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lowy F.D. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–532. doi: 10.1056/NEJM199808203390806. [DOI] [PubMed] [Google Scholar]
  • 3.Tong S.Y., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G., Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661. doi: 10.1128/CMR.00134-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Miller L.S., Cho J.S. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol. 2011;11:505–518. doi: 10.1038/nri3010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cho J.S., Pietras E.M., Garcia N.C., Ramos R.I., Farzam D.M., Monroe H.R., Magorien J.E., Blauvelt A., Kolls J.K., Cheung A.L., Cheng G., Modlin R.L., Miller L.S. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest. 2010;120:1762–1773. doi: 10.1172/JCI40891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cho J.S., Guo Y., Ramos R.I., Hebroni F., Plaisier S.B., Xuan C., Granick J.L., Matsushima H., Takashima A., Iwakura Y., Cheung A.L., Cheng G., Lee D.J., Simon S.I., Miller L.S. Neutrophil-derived IL-1beta is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog. 2012;8:e1003047. doi: 10.1371/journal.ppat.1003047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Nakane A., Okamoto M., Asano M., Kohanawa M., Minagawa T. Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect Immun. 1995;63:1165–1172. doi: 10.1128/iai.63.4.1165-1172.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sasaki S., Nishikawa S., Miura T., Mizuki M., Yamada K., Madarame H., Tagawa Y.I., Iwakura Y., Nakane A. Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon. Infect Immun. 2000;68:2424–2430. doi: 10.1128/iai.68.5.2424-2430.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sasaki S., Tagawa Y., Iwakura Y., Nakane A. The role of gamma interferon in acquired host resistance against Staphylococcus aureus infection in mice. FEMS Immunol Med Microbiol. 2006;46:367–374. doi: 10.1111/j.1574-695X.2005.00037.x. [DOI] [PubMed] [Google Scholar]
  • 10.Zhao Y.X., Tarkowski A. Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol. 1995;155:5736–5742. [PubMed] [Google Scholar]
  • 11.Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council . Guide for the Care and Use of Laboratory Animals: Eighth Edition. National Academies Press; Washington, DC: 2011. [Google Scholar]
  • 12.Davis M.F., Baron P., Price L.B., Williams D.L., Jeyaseelan S., Hambleton I.R., Diette G.B., Breysse P.N., McCormack M.C. Dry collection and culture methods for recovery of methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains from indoor home environments. Appl Environ Microbiol. 2012;78:2474–2476. doi: 10.1128/AEM.06886-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Garcia-Alvarez L., Holden M.T., Lindsay H., Webb C.R., Brown D.F., Curran M.D., Walpole E., Brooks K., Pickard D.J., Teale C., Parkhill J., Bentley S.D., Edwards G.F., Girvan E.K., Kearns A.M., Pichon B., Hill R.L., Larsen A.R., Skov R.L., Peacock S.J., Maskell D.J., Holmes M.A. Methicillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011;11:595–603. doi: 10.1016/S1473-3099(11)70126-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Shopsin B., Gomez M., Montgomery S.O., Smith D.H., Waddington M., Dodge D.E., Bost D.A., Riehman M., Naidich S., Kreiswirth B.N. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol. 1999;37:3556–3563. doi: 10.1128/jcm.37.11.3556-3563.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sasaki T., Tsubakishita S., Tanaka Y., Sakusabe A., Ohtsuka M., Hirotaki S., Kawakami T., Fukata T., Hiramatsu K. Multiplex-PCR method for species identification of coagulase-positive staphylococci. J Clin Microbiol. 2010;48:765–769. doi: 10.1128/JCM.01232-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhang K., McClure J.A., Elsayed S., Louie T., Conly J.M. Novel multiplex PCR assay for simultaneous identification of community-associated methicillin-resistant Staphylococcus aureus strains USA300 and USA400 and detection of mecA and Panton-Valentine leukocidin genes, with discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J Clin Microbiol. 2008;46:1118–1122. doi: 10.1128/JCM.01309-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Poyart C., Quesne G., Boumaila C., Trieu-Cuot P. Rapid and accurate species-level identification of coagulase-negative staphylococci by using the sodA gene as a target. J Clin Microbiol. 2001;39:4296–4301. doi: 10.1128/JCM.39.12.4296-4301.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Puel A., Cypowyj S., Bustamante J., Wright J.F., Liu L., Lim H.K., Migaud M., Israel L., Chrabieh M., Audry M., Gumbleton M., Toulon A., Bodemer C., El-Baghdadi J., Whitters M., Paradis T., Brooks J., Collins M., Wolfman N.M., Al-Muhsen S., Galicchio M., Abel L., Picard C., Casanova J.L. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332:65–68. doi: 10.1126/science.1200439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Boisson B., Wang C., Pedergnana V., Wu L., Cypowyj S., Rybojad M., Belkadi A., Picard C., Abel L., Fieschi C., Puel A., Li X., Casanova J.L. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity. 2013;39:676–686. doi: 10.1016/j.immuni.2013.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bae I.G., Tonthat G.T., Stryjewski M.E., Rude T.H., Reilly L.F., Barriere S.L., Genter F.C., Corey G.R., Fowler V.G., Jr. Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol. 2009;47:3952–3957. doi: 10.1128/JCM.01643-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Holtfreter S., Radcliff F.J., Grumann D., Read H., Johnson S., Monecke S., Ritchie S., Clow F., Goerke C., Broker B.M., Fraser J.D., Wiles S. Characterization of a mouse-adapted Staphylococcus aureus strain. PLoS One. 2013;8:e71142. doi: 10.1371/journal.pone.0071142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kim M.H., Granick J.L., Kwok C., Walker N.J., Borjesson D.L., Curry F.R., Miller L.S., Simon S.I. Neutrophil survival and c-kit(+)-progenitor proliferation in Staphylococcus aureus-infected skin wounds promote resolution. Blood. 2011;117:3343–3352. doi: 10.1182/blood-2010-07-296970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mohan K., Cordeiro E., Vaci M., McMaster C., Issekutz T.B. CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. Eur J Immunol. 2005;35:1702–1711. doi: 10.1002/eji.200425885. [DOI] [PubMed] [Google Scholar]
  • 24.Rivino L., Messi M., Jarrossay D., Lanzavecchia A., Sallusto F., Geginat J. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med. 2004;200:725–735. doi: 10.1084/jem.20040774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Song K., Rabin R.L., Hill B.J., De Rosa S.C., Perfetto S.P., Zhang H.H., Foley J.F., Reiner J.S., Liu J., Mattapallil J.J., Douek D.C., Roederer M., Farber J.M. Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans. Proc Natl Acad Sci U S A. 2005;102:7916–7921. doi: 10.1073/pnas.0409720102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mosser D.M. The many faces of macrophage activation. J Leukoc Biol. 2003;73:209–212. doi: 10.1189/jlb.0602325. [DOI] [PubMed] [Google Scholar]
  • 27.Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451–483. doi: 10.1146/annurev.immunol.021908.132532. [DOI] [PubMed] [Google Scholar]
  • 28.Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71–82. doi: 10.1016/s1074-7613(03)00174-2. [DOI] [PubMed] [Google Scholar]
  • 29.van Rooijen N., van Kesteren-Hendrikx E. “In vivo” depletion of macrophages by liposome-mediated “suicide”. Methods Enzymol. 2003;373:3–16. doi: 10.1016/s0076-6879(03)73001-8. [DOI] [PubMed] [Google Scholar]
  • 30.Liao F., Rabin R.L., Yannelli J.R., Koniaris L.G., Vanguri P., Farber J.M. Human Mig chemokine: biochemical and functional characterization. J Exp Med. 1995;182:1301–1314. doi: 10.1084/jem.182.5.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Teruya-Feldstein J., Jaffe E.S., Burd P.R., Kanegane H., Kingma D.W., Wilson W.H., Longo D.L., Tosato G. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood. 1997;90:4099–4105. [PubMed] [Google Scholar]
  • 32.Eck M., Schmausser B., Scheller K., Toksoy A., Kraus M., Menzel T., Muller-Hermelink H.K., Gillitzer R. CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis. Clin Exp Immunol. 2000;122:192–199. doi: 10.1046/j.1365-2249.2000.01374.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ciccia F., Alessandro R., Rizzo A., Accardo-Palumbo A., Raimondo S., Raiata F., Guggino G., Giardina A., De Leo G., Sireci G., Triolo G. Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis. Rheumatology. 2014;53:104–113. doi: 10.1093/rheumatology/ket323. [DOI] [PubMed] [Google Scholar]
  • 34.Schwarzenberger P., Kolls J.K. Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J Cell Biochem Suppl. 2002;38:88–95. doi: 10.1002/jcb.10054. [DOI] [PubMed] [Google Scholar]
  • 35.Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., Fujikado N., Tanahashi Y., Akitsu A., Kotaki H., Sudo K., Nakae S., Sasakawa C., Iwakura Y. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009;30:108–119. doi: 10.1016/j.immuni.2008.11.009. [DOI] [PubMed] [Google Scholar]
  • 36.Gaffen S.L., Jain R., Garg A.V., Cua D.J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585–600. doi: 10.1038/nri3707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9:556–567. doi: 10.1038/nri2586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lin L., Ibrahim A.S., Xu X., Farber J.M., Avanesian V., Baquir B., Fu Y., French S.W., Edwards J.E., Jr., Spellberg B. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009;5:e1000703. doi: 10.1371/journal.ppat.1000703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Conti H.R., Whibley N., Coleman B.M., Garg A.V., Jaycox J.R., Gaffen S.L. Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. PLoS One. 2015;10:e0122807. doi: 10.1371/journal.pone.0122807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–238. doi: 10.1038/nature04753. [DOI] [PubMed] [Google Scholar]
  • 41.Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123–1132. doi: 10.1038/ni1254. [DOI] [PubMed] [Google Scholar]
  • 42.Damsker J.M., Hansen A.M., Caspi R.R. Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci. 2010;1183:211–221. doi: 10.1111/j.1749-6632.2009.05133.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179–189. doi: 10.1016/j.immuni.2006.01.001. [DOI] [PubMed] [Google Scholar]
  • 44.Lee Y.K., Mukasa R., Hatton R.D., Weaver C.T. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009;21:274–280. doi: 10.1016/j.coi.2009.05.021. [DOI] [PubMed] [Google Scholar]
  • 45.Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., Duquette P., Prat A. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann Neurol. 2009;66:390–402. doi: 10.1002/ana.21748. [DOI] [PubMed] [Google Scholar]
  • 46.Hirota K., Duarte J.H., Veldhoen M., Hornsby E., Li Y., Cua D.J., Ahlfors H., Wilhelm C., Tolaini M., Menzel U., Garefalaki A., Potocnik A.J., Stockinger B. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol. 2011;12:255–263. doi: 10.1038/ni.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sallusto F., Zielinski C.E., Lanzavecchia A. Human Th17 subsets. Eur J Immunol. 2012;42:2215–2220. doi: 10.1002/eji.201242741. [DOI] [PubMed] [Google Scholar]
  • 48.Peters A., Lee Y., Kuchroo V.K. The many faces of Th17 cells. Curr Opin Immunol. 2011;23:702–706. doi: 10.1016/j.coi.2011.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., Soudais C., Dupuis S., Feinberg J., Fieschi C., Elbim C., Hitchcock R., Lammas D., Davies G., Al-Ghonaium A., Al-Rayes H., Al-Jumaah S., Al-Hajjar S., Al-Mohsen I.Z., Frayha H.H., Rucker R., Hawn T.R., Aderem A., Tufenkeji H., Haraguchi S., Day N.K., Good R.A., Gougerot-Pocidalo M.A., Ozinsky A., Casanova J.L. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 2003;299:2076–2079. doi: 10.1126/science.1081902. [DOI] [PubMed] [Google Scholar]
  • 50.Picard C., von Bernuth H., Ghandil P., Chrabieh M., Levy O., Arkwright P.D. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine. 2010;89:403–425. doi: 10.1097/MD.0b013e3181fd8ec3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.von Bernuth H., Picard C., Jin Z., Pankla R., Xiao H., Ku C.L. Pyogenic bacterial infections in humans with MyD88 deficiency. Science. 2008;321:691–696. doi: 10.1126/science.1158298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Gonzalez-Barca E., Carratala J., Mykietiuk A., Fernandez-Sevilla A., Gudiol F. Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis. 2001;20:117–119. doi: 10.1007/pl00011241. [DOI] [PubMed] [Google Scholar]
  • 53.Andrews T., Sullivan K.E. Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev. 2003;16:597–621. doi: 10.1128/CMR.16.4.597-621.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Winterbourn C.C., Kettle A.J., Hampton M.B. Reactive Oxygen Species and Neutrophil Function. Annu Rev Biochem. 2016;85:765–792. doi: 10.1146/annurev-biochem-060815-014442. [DOI] [PubMed] [Google Scholar]
  • 55.Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953–964. doi: 10.1038/nri1733. [DOI] [PubMed] [Google Scholar]
  • 56.Hamza T., Li B. Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection. BMC Microbiol. 2014;14:207. doi: 10.1186/s12866-014-0207-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Dey S., Bishayi B. Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin. J Inflamm Res. 2015;8:29–47. doi: 10.2147/JIR.S76045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Das D., Bishayi B. Staphylococcal catalase protects intracellularly survived bacteria by destroying H2O2 produced by the murine peritoneal macrophages. Microb Pathog. 2009;47:57–67. doi: 10.1016/j.micpath.2009.04.012. [DOI] [PubMed] [Google Scholar]
  • 59.Das D., Bishayi B. Contribution of Catalase and Superoxide Dismutase to the Intracellular Survival of Clinical Isolates of Staphylococcus aureus in Murine Macrophages. Indian J Microbiol. 2010;50:375–384. doi: 10.1007/s12088-011-0063-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Smith R.P., Baltch A.L., Ritz W.J., Michelsen P.B., Bopp L.H. IFN-gamma enhances killing of methicillin-resistant Staphylococcus aureus by human monocytes more effectively than GM-CSF in the presence of daptomycin and other antibiotics. Cytokine. 2010;51:274–277. doi: 10.1016/j.cyto.2010.06.004. [DOI] [PubMed] [Google Scholar]
  • 61.Wu L., Ong S., Talor M.V., Barin J.G., Baldeviano G.C., Kass D.A., Bedja D., Zhang H., Sheikh A., Margolick J.B., Iwakura Y., Rose N.R., Cihakova D. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J Exp Med. 2014;211:1449–1464. doi: 10.1084/jem.20132126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Groom J.R., Luster A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. 2011;89:207–215. doi: 10.1038/icb.2010.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol. 1997;61:246–257. [PubMed] [Google Scholar]
  • 64.Martin F.J., Parker D., Harfenist B.S., Soong G., Prince A. Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung. Infect Immun. 2011;79:1898–1904. doi: 10.1128/IAI.01299-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., Koch A.E., Moser B., Mackay C.R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998;101:746–754. doi: 10.1172/JCI1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187:875–883. doi: 10.1084/jem.187.6.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., Anderson V.L., Darnell D.N., Welch P.A., Kuhns D.B., Frucht D.M., Malech H.L., Gallin J.I., Kobayashi S.D., Whitney A.R., Voyich J.M., Musser J.M., Woellner C., Schaffer A.A., Puck J.M., Grimbacher B. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–1619. doi: 10.1056/NEJMoa073687. [DOI] [PubMed] [Google Scholar]
  • 68.Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., Metin A., Karasuyama H. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–1062. doi: 10.1038/nature06096. [DOI] [PubMed] [Google Scholar]
  • 69.Puel A., Cypowyj S., Marodi L., Abel L., Picard C., Casanova J.L. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012;12:616–622. doi: 10.1097/ACI.0b013e328358cc0b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Paulson M.L., Freeman A.F., Holland S.M. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol. 2008;8:527–533. doi: 10.1097/ACI.0b013e3283184210. [DOI] [PubMed] [Google Scholar]
  • 71.Ito R., Mori M., Katakura S., Kobayashi N., Naruto T., Osamura Y., Aihara Y., Yokota S. Selective insufficiency of IFN-gamma secretion in patients with hyper-IgE syndrome. Allergy. 2003;58:329–336. doi: 10.1034/j.1398-9995.2003.00099.x. [DOI] [PubMed] [Google Scholar]
  • 72.Paganelli R., Scala E., Capobianchi M.R., Fanales-Belasio E., D'Offizi G., Fiorilli M., Aiuti F. Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis. Clin Exp Immunol. 1991;84:28–33. [PMC free article] [PubMed] [Google Scholar]
  • 73.Del Prete G., Tiri A., Maggi E., De Carli M., Macchia D., Parronchi P., Rossi M.E., Pietrogrande M.C., Ricci M., Romagnani S. Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome. J Clin Invest. 1989;84:1830–1835. doi: 10.1172/JCI114368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Thammavongsa V., Missiakas D.M., Schneewind O. Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science. 2013;342:863–866. doi: 10.1126/science.1242255. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES